CSIMarket
 
Accustem Sciences Inc   (ACUT)
 

Accustem Sciences Inc's Customers Performance

ACUT



 
ACUT's Source of Revenues During the corresponding time, Accustem Sciences Inc While revenue at the Accustem Sciences Inc 's corporate clients

List of ACUT Customers




for the same period Accustem Sciences Inc

List of ACUT Customers

Accustem Sciences Inc's Business Units






Accustem Sciences Inc's Comment on Sales, Marketing and Customers



The company focuses on the breast cancer market, specifically targeting endocrine receptor positive (ER+) breast cancer patients, who represent approximately 75% of breast cancer cases. Their product, StemPrintER, is intended for early-stage breast cancer patients, particularly those who are ER+/HER2-. The assay is designed to assess a patient's risk of recurrence to support treatment planning. The estimated U.S. patient population for this market is 214,000, with a serviceable market opportunity exceeding $800 million annually. StemPrintER was developed and validated using patient data from the IEO and the TransATAC trial, emphasizing the biological role of cancer stem cells in predicting patient outcomes.





Accustem Sciences Inc’s Comment on Sales, Marketing and Customers


The company focuses on the breast cancer market, specifically targeting endocrine receptor positive (ER+) breast cancer patients, who represent approximately 75% of breast cancer cases. Their product, StemPrintER, is intended for early-stage breast cancer patients, particularly those who are ER+/HER2-. The assay is designed to assess a patient's risk of recurrence to support treatment planning. The estimated U.S. patient population for this market is 214,000, with a serviceable market opportunity exceeding $800 million annually. StemPrintER was developed and validated using patient data from the IEO and the TransATAC trial, emphasizing the biological role of cancer stem cells in predicting patient outcomes.








ACUT's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Accustem Sciences Inc 2.89 0.00 -1.80 4
SUBTOTAL 0.00 0.00 0.00 -

Sources: Accustem Sciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Accustem Sciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Accustem Sciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.